Company Directory / research
PrivateFor profitresearchLeiden, Netherlands
Leyden Labs
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
- Founded
- 2020 6 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $187M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
6 years old.
Reach
Website ranked #9,265,841 in the world for traffic, about 417 visits a month.
What it does
BiotechnologyLife ScienceTherapeutics
Funding, as listed
$187M currency not stated
- Rounds2
- LatestSeries b, Jan 2022
- Investors7, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Leyden Labs, field by field. Contact details are held but never shown.
The company
- Name
- Leyden Labs
- Type
- For profit
- Status
- Private
- Founded
- 2020
- Founders
- Dinko Valerio, Jaap Goudsmit, Koenraad Wiedhaup, Ronald Brus
- Industry
- research
- Categories
- Biotechnology, Life Science, Therapeutics
Where
- City
- Leiden
- Country
- Netherlands
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #9,265,841
- Monthly web visits
- 417
Funding, as listed
- Total
- 187,105,929 (currency not stated)
- Rounds
- 2
- Latest round
- Series b
- Latest round date
- Jan 2022
- Investors
- 7
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Leyden Labs may be growing as it has been listed among notable investments by a general partner at GV, indicating a recognition of its potential and financial backing. This inclusion suggests that Leyden Labs has secured venture capital investment, which is a positive indicator of growth and investor confidence. Furthermore, Leyden Labs is mentioned alongside other companies in a context that implies it is part of a portfolio for investors focusing on biotechnology and therapeutics, industries known for their high growth potential.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Netherlands.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 174,966 companies in Netherlands and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.